Statements (21)
Predicate | Object |
---|---|
gptkbp:instanceOf |
antiviral drug
|
gptkbp:activeIngredient |
gptkb:brincidofovir
|
gptkbp:approvalYear |
2021
|
gptkbp:approvedBy |
gptkb:FDA
|
gptkbp:ATCCode |
J05AB15
|
gptkbp:CASNumber |
444805-28-1
|
gptkbp:chemicalFormula |
C27H52N3O7P
|
gptkbp:developer |
gptkb:Chimerix
|
https://www.w3.org/2000/01/rdf-schema#label |
Tembexa
|
gptkbp:legalStatus |
prescription only
|
gptkbp:mechanismOfAction |
inhibits viral DNA polymerase
|
gptkbp:pregnancyCategory |
Not assigned (US)
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain |
gptkbp:usedFor |
treatment of smallpox
|
gptkbp:bfsParent |
gptkb:Chimerix
gptkb:brincidofovir |
gptkbp:bfsLayer |
7
|